CAMBRIDGE, UK –3 March 2008 – TeraView, (www.teraview.com) the global pioneer and leader in terahertz solutions for pharmaceutical, chemical and research industries, has developed a new terahertz spectrometer. Complementing TeraView’s existing range of unique imaging solutions, the Spectra 3000 is the world’s first commercial terahertz spectrometer capable of performing both transmission and attenuated total reflection (ATR) measurements.
TeraView’s proprietary platform uses the terahertz region of the spectrum between light and radio waves and offers the advantage of being non-invasive and non-destructive. Terahertz uniquely provides rapid and accurate chemical and structural identification of materials normally invisible to conventional techniques.
Terahertz radiation interrogates the fundamental vibrations between molecules, providing inter-molecular information previously difficult to obtain.
TeraView’s Spectra 3000 is a unique approach to spectroscopy offering:
• Modular design
• ATR, transmission and other standard spectrometer accessories
• Transmission imaging and stand off explosives detection accessories available
• Fast, reliable and easy to use
• Rapid, repeatable non-destructive sample testing
Typical applications for the new spectrometer include providing information on crystalline structure, investigating and identifying polymorphs, explosives fingerprinting and airborne agent/gas phase detection, and investigation of pharmaceutical tablet constituents.
Dr Don Arnone, Chief Executive Officer of TeraView commented: “The development of the new Spectra 3000 is exciting news for the analytical industry. It enables us to provide terahertz solutions which complement existing technologies while offering new and unique analytical information to the user, not available at other wavelengths”. Don Arnone added “It is an innovative product solution designed to satisfy the most demanding spectroscopy requirements across industrial, scientific, R & D and environmental applications”.
A high resolution photograph of TeraView’s Spectra 3000 spectrometer is available at www.teraview.com/graphic/
For more information about TeraView’s terahertz spectroscopy solutions please visit www.teraview.com or contact us at enquiries@teraview.com
About TeraView (www.teraview.com)
TeraView is the world’s first company devoted to the application of terahertz light for spectroscopy and imaging in pharmaceutical drug development and manufacture. TeraView’s technology can improve the quality of pharmaceutical products and decrease the risk of regulatory non-compliance, leading to potentially safer tablets and savings arising from faster times to market and volume production of higher quality, stable products.
Other markets for the technology exist in early stage cancer detection, defence and industrial inspection. Headquartered in Cambridge, UK, TeraView was spun-out of the Toshiba Cambridge Research Laboratory in April 2001. Sales and support are available throughout Europe, North America and the Far East either directly or through a network of distributors.
– ends –
For further information, please contact:
For Europe and Asia:
David Reece, TeraView Ltd
Tel: +44 (0)1223 435380
david.reece@teraview.com
For North America:
Edward Pankau, TeraView Ltd
Tel: +1 847 426 6247
edward.pankau@teraview.com
Press enquiries to:
Helen Thurley, TeraView Ltd
+44 (0)1223 435 380
helen.thurley@teraview.com
www.teraview.com
|
